MEN1 and neoplasm: In MEN1 patients, it has also been shown that early onset pancreatic microadenomas with loss of heterozygosity (LOH) of MEN1 express glucagon, whereas more advanced hormone-secreting tumours in the same patients were predominantly insulinomas (34, 35).